MiRNA-based Regenerative therapy for DM: MIRNA-214 increases insulin-secreting cell mass and function via up regulation of its target genes, 17/October/2014, 06.47 am

Natural product-based therapy for Hypertension: Resveratrol, a longevity- promoting compound isolated from grapes and groundnut, decreases renal oxidative stress and blood pressure via up regulation of its target gene, 16/October/2014, 7.56 am
October 16, 2014
Molecular therapy for Alzheimer’s disease: Tumor suppressor ING1B decreases Tau expression via up regulation of its target gene, 17/October/2014, 6.54 am
October 17, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, MiRNA-based Regenerative therapy for DM: MIRNA-214 increases insulin-secreting cell mass and function via up regulation of its target genes, 17/October/2014, 06.47 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Significance:   This study suggests, for the first time, that  MIRNA-214, by increasing the expression of its target gene, it may increase insulin-secreting cell mass and function. Thereby, it may increase the insulin sensitivity of cellular tissues.  Thus, pharmacological formulations encompassing “MIRNA-214 or its activator”  may be used to treat DM.

Comments are closed.